Neuroendocrine Peptide Catestatin Clears MRSA Skin Infections by Activating Mast Cells | Research

The takeaway

Topical catestatin accelerated MRSA-infected wound healing and reduced bacterial burden by activating mast cells via Mrgprb2/MRGPRX2 receptor, which upregulated β-defensin-14 antimicrobial peptide production.

Immune activation, not direct killing
Catestatin fights MRSA by activating mast cells that produce β-defensin-14, not by directly killing bacteria

What the researchers found

Topical CST accelerated MRSA wound healing and reduced bacterial burden through Mrgprb2-dependent mast cell activation, suppressed inflammation, and upregulated β-defensin-14 production.

Why it matters

MRSA skin infections are common, dangerous, and increasingly antibiotic-resistant. A natural peptide that activates the body's own antimicrobial defense through mast cells offers a fundamentally new treatment approach.

How the study worked

MRSA wound infection in WT and Mrgprb2-KO mice, topical CST treatment, bacterial burden quantification, inflammatory cytokine/leukocyte analysis, immortalized human mast cell MRGPRX2 studies, and signaling pathway characterization.

What this study cannot tell us

Mouse model. Mrgprb2 is the murine ortholog of human MRGPRX2; exact translation uncertain. Optimal CST topical formulation not optimized.

How to read the evidence

Comprehensive preclinical study with WT/KO mouse comparison, human mast cell validation, and full pathway characterization. Strong mechanistic evidence.

When this study was published

Published in 2025.

The bigger picture

CST exemplifies "immunomodulatory antimicrobial therapy" — rather than directly killing bacteria, it activates the body's own immune cells to fight infection.

Questions still open

Could CST cream/gel be developed for clinical MRSA wound treatment?
Would CST work against other skin pathogens beyond MRSA?
Does chronic CST application maintain efficacy or cause mast cell exhaustion?

Common questions

How does catestatin fight MRSA?

Rather than directly killing bacteria, catestatin activates mast cells in the skin through the MRGPRX2 receptor. These activated mast cells then produce β-defensin-14, a natural antibiotic, and control inflammation to promote healing.

Could this become a cream for skin infections?

Potentially. Topical catestatin cleared MRSA from wounds in mice. Developing it as a cream or gel for human skin infections is a logical next step, though clinical trials would be needed.

Read the original research

The neuroendocrine peptide catestatin promotes clearance of cutaneous Staphylococcus aureus through mast cell Mrgpr activation.

Mucosal immunology

View on PubMed ↗Publisher’s paper ↗

Citation

Guth, Colin; Dychtenberg, Hannah; Rudolph, Erin; Pozniak, Austin; Pundir, Priyanka. (2026). The neuroendocrine peptide catestatin promotes clearance of cutaneous Staphylococcus aureus through mast cell Mrgpr activation.. Mucosal immunology. https://doi.org/10.1016/j.mucimm.2026.03.003